Rapid-Action IV Beta-Blocker for Critical Care Heart Rate Control
Esmolol Hydrochloride Injection 100mg/10mL by Mylan Institutional is an essential, fast-acting intravenous β1-selective adrenergic blocker for acute cardiovascular management in emergency and hospital settings. Each box contains 10 single-dose, ready-to-administer vials—offering reliable, consistent dosing for urgent heart rate and rhythm control. Ideal for acute supraventricular tachycardia (SVT), atrial fibrillation/flutter, hypertensive emergencies, and perioperative arrhythmia management.
Key Features & Uses
-
Ultra-Short Acting Beta-Blocker: Immediate onset, short duration—ideal for titration and rapid reversal if needed.
-
IV Formulation for Critical Situations: Supports precise, controlled administration in operating rooms, ICUs, emergency departments, and cardiac care units.
-
Trusted for Arrhythmia & Hypertension: Proven efficacy for rapid reduction of ventricular rate in SVT and non-compensatory sinus tachycardia; effective perioperative, postoperative beta-blockade.
-
Consistent, Sterile, Single-Dose Vials: 10mL vials for convenience, safety, and infection control in medical facilities.
Clinical Benefits & Applications
- Acute Supraventricular Tachycardia (SVT) Treatment
- Rapid Ventricular Rate Control in Atrial Fibrillation or Flutter
- Perioperative Tachyarrhythmia Management
- Hypertensive Crisis/Hypertensive Emergency
- Reduces Myocardial Oxygen Demand, Prevents Cardiac Events
- Easily Titrated—Predictable Pharmacokinetics for Safe Dosing
Esmolol HCl delivers swift, short-lived beta-blockade, allowing for seamless transition or cessation and ultimate clinician control in unpredictable critical care scenarios. Safeguard patients experiencing acute hemodynamic instability, tachycardia, or arrhythmias with the leading parenteral beta-blocker trusted by top hospitals.
Why Choose Esmolol Hydrochloride Injection by Mylan Institutional?
-
Highest Purity & Stability: Manufactured to the strictest U.S. quality and safety standards for hospital use.
-
Ready-to-Use, Preservative-Free vials reduce risk of contamination, ensure consistent medication delivery.
-
Broad Hospital Supply Applications: Essential for code carts, anesthesia, surgical, ER, CCU, and ICU protocols.
-
NDC: 67457-0182-10 for seamless ordering and compliance.
How to Administer
-
For IV use only. Administer as a slow bolus or carefully titrated infusion under continuous cardiac monitoring.
-
Dosing individualized according to patient weight, indication, and clinical response.
-
Supervision by trained healthcare professionals required in a hospital setting.
Consult full prescribing information for precise instructions, dosing guidelines, and contraindications.
Frequently Asked Questions (FAQ)
Q: What is Esmolol Injection used for? A: Esmolol is used for rapid control of ventricular rate in supraventricular tachyarrhythmias, perioperative cardiac arrhythmia, and hypertensive emergencies.
Q: Where should Esmolol IV be administered? A: For IV use in controlled healthcare settings—hospitals, surgical centers, and critical care units—by medical professionals.
Q: What are the main advantages of Esmolol over oral beta-blockers? A: Esmolol IV has a rapid onset and short duration, ideal for acute situations needing rapid heart rate control and flexible titration.
Q: Is this safe for all patients? A: Not suitable for patients with certain heart blocks, severe bradycardia, uncompensated heart failure, or known hypersensitivity. Always consider the contraindications and monitor closely.
Ensure Patient Safety and Effective Intervention with Esmolol Hydrochloride Injection by Mylan Institutional!
Order now—Esmolol Hydrochloride Injection 100mg/10mL Single-Dose Vials (10 per box, NDC 67457-0182-10) for reliable, immediate heart rate and arrhythmia control. Streamline your pharmaceutical supply chain with trusted, hospital-grade beta-blocker therapy.
Turn to Mylan Institutional for premium injectable cardiovascular medications—Esmolol Hydrochloride Injection: the gold standard for acute rate and rhythm management in critical care.
